查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1701957

2025 年至 2033 年避孕藥市場報告（按產品、年齡層、配銷通路和地區）

Contraceptive Drugs Market Report by Product, Age Group, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2024年全球避孕藥市場規模達166億美元。展望未來， IMARC Group預計到2033年市場規模將達到255億美元，2025-2033年期間的成長率（CAGR）為4.64%。

避孕藥是指用來預防懷孕、控制生育的藥物。它們採用兩種女性激素，即雌激素和黃體激素合成配製而成，可防止排卵。這些荷爾蒙也會使子宮頸黏液變稠或改變子宮內膜，以阻止精子進入子宮頸進行受精和著床。避孕藥有助於降低痤瘡、骨質疏鬆、卵巢癌、輸卵管和子宮感染以及經前症候群（PMS）的風險。因此，醫療保健從業者會使用這些藥物來抑制育齡婦女的意外懷孕。目前主要有口服、注射、外用劑型。

避孕藥市場趨勢：

推動全球避孕藥市場發展的關鍵因素之一是消費者計劃生育意識的增強、人口的成長以及意外懷孕案例的增加。與此一致，由於現代避孕方法具有多種優勢（包括最佳安全性和更好的臨床結果），醫療保健從業人員越來越傾向於採用現代避孕方法而非傳統方法，這成為另一個促進成長的因素。此外，美國食品藥物管理局 (FDA) 等多個監管機構經常批准新藥，也支持了市場的成長。此外，明膠膠囊和非荷爾蒙陰道凝膠的出現透過維持陰道 pH 值為精子創造一個不適合生存的環境，推動了市場的成長。除此之外，持續的研究和發展 (R&D) 活動以及非政府組織 (NGO) 和衛生機構為提高消費者對避孕技術、婦女健康和性健康的認知而採取的有利舉措正在積極促進市場成長。

本報告回答的關鍵問題

  • 2024 年全球避孕藥市場規模？ 2025-2033年全球避孕藥市場的預期成長率是多少？
  • 推動全球避孕藥市場發展的關鍵因素有哪些？
  • COVID-19 對全球避孕藥市場有何影響？
  • 根據產品，全球避孕藥市場是如何分佈的？
  • 全球避孕藥市場依年齡層分類的分佈如何？
  • 根據配銷通路，全球避孕藥市場如何分佈？
  • 全球避孕藥市場的主要地區有哪些？
  • 全球避孕藥市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球避孕藥市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 口服避孕藥
  • 注射避孕藥
  • 局部避孕藥

第7章：市場區隔：依年齡段

  • 15-24歲
  • 25-34歲
  • 35-44歲
  • 44歲以上

第8章：市場區隔：按配銷通路

  • 零售藥局
  • 醫院藥房
  • 診所
  • 線上通路
  • 公共管道和非政府組織
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc.
    • Afaxys Inc.
    • Agile Therapeutics
    • Amneal Pharmaceuticals Inc.
    • Bayer AG
    • Johnson & Johnson
    • Mithra Pharmaceuticals SA
    • Novartis AG
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: SR112025A6300

The global contraceptive drugs market size reached USD 16.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.64% during 2025-2033.

Contraceptive drugs refer to birth control medications that are used to prevent pregnancy and control the birth rate. They are synthetically formulated using two female hormones, namely estrogen and progestin, which prevent ovulation. These hormones also thicken cervical mucus or alter the womb lining to prohibit the entrance of sperm into the cervix for fertilization and implantation. Contraceptive drugs assist in lowering the risks of acne, bone thinning, ovarian cancer, infections in the fallopian tubes and uterus, and premenstrual syndrome (PMS). As a result, they are administered by healthcare practitioners to inhibit unwanted pregnancy amongst women of childbearing age. At present, they are mainly available in oral, injectable, and topical formulations.

Contraceptive Drugs Market Trends:

One of the key factors driving the global contraceptive drugs market is the rising consumer consciousness regarding family planning, the increasing population, and the rising instances of unintended pregnancies. In line with this, the shifting inclination of healthcare practitioners toward modern contraceptive methods over conventional procedures, owing to their multiple benefits, including optimal safety, and better clinical outcomes, are acting as another growth-inducing factor. Additionally, the frequent approvals of novel medications by several regulatory bodies, such as the food and drug administration (FDA), are supporting the market growth. Moreover, the advent of gelatin capsules and non-hormonal vaginal gels that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is impelling the market growth. Apart from this, continuous research and development (R&D) activities and the favorable initiatives undertaken by non-governmental organizations (NGOs) and health agencies to sensitize consumers about contraception techniques, women's health, and sexual wellness are positively augmenting the market growth.

Key Market Segmentation:

Breakup by Product:

  • Oral Contraceptive Pills
  • Injectable Contraceptives
  • Topical Contraceptives

Breakup by Age Group:

  • 15-24 years
  • 25-34 years
  • 35-44 years
  • Above 44 years

Breakup by Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Clinics
  • Online Channel
  • Public Channel and NGOs
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global contraceptive drugs market in 2024?
  • 2.What is the expected growth rate of the global contraceptive drugs market during 2025-2033?
  • 3.What are the key factors driving the global contraceptive drugs market?
  • 4.What has been the impact of COVID-19 on the global contraceptive drugs market?
  • 5.What is the breakup of the global contraceptive drugs market based on the product?
  • 6.What is the breakup of the global contraceptive drugs market based on the age group?
  • 7.What is the breakup of the global contraceptive drugs market based on the distribution channel?
  • 8.What are the key regions in the global contraceptive drugs market?
  • 9.Who are the key players/companies in the global contraceptive drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Contraceptive Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oral Contraceptive Pills
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Contraceptives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Contraceptives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 15-24 years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 25-34 years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 35-44 years
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Above 44 years
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Channel
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Public Channel and NGOs
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Afaxys Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Agile Therapeutics
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Amneal Pharmaceuticals Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bayer AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mithra Pharmaceuticals SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Viatris Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Contraceptive Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Contraceptive Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Contraceptive Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Contraceptive Drugs Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Contraceptive Drugs Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Contraceptive Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Contraceptive Drugs Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Contraceptive Drugs (Injectable Contraceptives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Contraceptive Drugs (Injectable Contraceptives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Contraceptive Drugs (Topical Contraceptives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Contraceptive Drugs (Topical Contraceptives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Contraceptive Drugs (15-24 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Contraceptive Drugs (15-24 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Contraceptive Drugs (25-34 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Contraceptive Drugs (25-34 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Contraceptive Drugs (35-44 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Contraceptive Drugs (35-44 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Contraceptive Drugs (Above 44 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Contraceptive Drugs (Above 44 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Contraceptive Drugs (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Contraceptive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Contraceptive Drugs (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Contraceptive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Contraceptive Drugs (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Contraceptive Drugs (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Contraceptive Drugs (Online Channel) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Contraceptive Drugs (Online Channel) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Contraceptive Drugs (Public Channel and NGOs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Contraceptive Drugs (Public Channel and NGOs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Contraceptive Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Contraceptive Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Contraceptive Drugs Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Contraceptive Drugs Industry: SWOT Analysis
  • Figure 84: Global: Contraceptive Drugs Industry: Value Chain Analysis
  • Figure 85: Global: Contraceptive Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Contraceptive Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Contraceptive Drugs Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Contraceptive Drugs Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Contraceptive Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Contraceptive Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Contraceptive Drugs Market: Competitive Structure
  • Table 7: Global: Contraceptive Drugs Market: Key Players